Diagnosis and treatment of family combined hyperlipidemia

Authors

  • O. A. Golubeva FGU RKNPK MH and SR RF
  • M. G. Tvorogova State Research Center for Preventive Medicine of the Ministry of Health and the Russian Federation
  • P. P. Malyshev FGU RKNPK MH and SR RF
  • A. V. Maksimenko National Medical Research Center of Cardiology of the Ministry of Health of the Russian Federation
  • A. D. Turashev National Medical Research Center of Cardiology of the Ministry of Health of the Russian Federation
  • A. A. Fedorovich National Medical Research Center of Cardiology of the Ministry of Health of the Russian Federation
  • E. G. Tischenko National Medical Research Center of Cardiology of the Ministry of Health of the Russian Federation
  • A. N. Rogoza National Medical Research Center of Cardiology of the Ministry of Health of the Russian Federation

Keywords:

ischemic heart disease, lovastatin, familial combined hyperlipidemia, triglycerides, cholesterol

Abstract

Family combined hyperlipidemia (FCH) - one of the most common inherited form of hyperlipidemia, and is associated with an increased risk of CHD. In clinical practice, the disease often goes unrecognized, leading to a later appointment treatment. The article describes the diagnosis and treatment FCH in families. Presented research data demonstrating the characteristic of the disease indices of lipid disorders and transportation system.

Downloads

Download data is not yet available.

Downloads

Published

2011-09-25

How to Cite

Golubeva O. A., Tvorogova M. G., Malyshev P. P., Maksimenko A. V., Turashev A. D., Fedorovich A. A., Tischenko E. G., Rogoza A. N. Diagnosis and treatment of family combined hyperlipidemia // The Journal of Atherosclerosis and Dyslipidemias. 2011. VOL. № 3 (4). PP. 52–55.

Issue

No. 3 (4) (2011)

Section

Clinical Case

Most read articles by the same author(s)

<< < 1 2